橡マニュアルv4c.PDF

Similar documents
LC/TOF-MS MS ( )

PowerPoint プレゼンテーション

スライド 1

Adenosine Triphosphate Adenosine Monophosphate min min Fig.2 Chromatograms of Nucleotides Peak

Microsoft Word - 14_LCMS_アクリルアミド

平成26年度 化学物質分析法開発報告書

平成26年度 化学物質分析法開発報告書

Ⅱ6.3界面活性剤

h1_4.ai

物理化学I-第11回(13).ppt

Agilent Infinity ELSD ELSD ( ) ( ºC ) W x D x H mm LED ELSD ELSD ELSD UV UV LC/MS RSD % Column: Agilent Pursuit C8, x.6 mm, µm Eluent: Water: Acetonit

xxxxEN.qxd

Adenosine Triphosphate Adenosine Monophosphate min Fig.2 Chromatograms of Nucleotides min Peak

mastro_nakamen三校.ai

2 Zn Zn + MnO 2 () 2 O 2 2 H2 O + O 2 O 2 MnO 2 2 KClO 3 2 KCl + 3 O 2 O 3 or 3 O 2 2 O 3 N 2 () NH 4 NO 2 2 O + N 2 ( ) MnO HCl Mn O + CaCl(ClO

Mastro -リン酸基含有化合物分析に対する新規高耐圧ステンレスフリーカラムの有用性について-

LC LC ACQUITY UPLC H-Class ACQUITY UPLC CSH C mm 1.7 µm : THF/ 2/8 A 1 mm / 4/6 THF 2 mg/ml THF/ 2 THF 2 ACQUITY UPLC CSH C 18

H22応用物理化学演習1_濃度.ppt

1 WSV SIR m/z Analyte RT (Min) SIR m/z Cone voltage (V) Ascorbic Acid (C) Thiamine (B1) Nicotinic Acid (B3) Pyridoxal (

Microsoft Word - 目次注意事項2.doc

untitled

(Microsoft PowerPoint \220\205\212\302\213\253\203V\203\223\203|\214\366\212J\227p.ppt)

まえがき

薬物分析法の開発

COSMOSIL.indd

外因性内分泌攪乱化学物質調査暫定マニュアル(水質、底質、水生生物)

近畿中国四国農業研究センター研究報告 第7号

<4D F736F F D F90858C6E5F C B B B838B>

A4冊子1P-P20.ai

untitled

low_ JAJP.qxd

untitled

HPLC 1M KH 2 PO 4 ph ml Anthranilic acid: AnA 600 ml ml AnA 1.0 ml / min Anthranilic acid= PRESSURE 140 kgf / cm 2

CH 2 CH CH 2 CH CH 2 CH CH 2 CH 2 COONa CH 2 N CH 2 COONa O Co 2+ O CO CH 2 CH N 2 CH 2 CO 9 Change in Ionic Form of IDA resin with h ph CH 2 NH + COO

Metabolomic Profiling_JA.qxp


土壌の観察・実験テキスト −土壌を調べよう!−

JAJP.qxp

Microsoft PowerPoint - LCテクノ ポスター 塚本

SEC (SEC) SEC SEC SEC 2

untitled

バイアル新規ユーザー様限定 ガラス製容器 -Si-O H シラノール -Si-O H -Si O -Si イオン的吸着 疎水的吸着シロキサン logp pka + N 塩基性化合物 疎水的吸着 水溶液 P P 製容器, 7,7

☆H23 13-農薬一斉分析(大垣).doc

第4次酸性雨全国調査報告書(平成16年度) -(Ⅱ)付表編-

H22環境地球化学4_化学平衡III_ ppt

橡A PDF

パーキンソン病治療ガイドライン2002

4 1 Ampère 4 2 Ampere 31

研修コーナー

JP.qxd


VOL. 25 NO. 6 CHEMOTHERAPY 1667

09_organal2

平成26年度 化学物質分析法開発報告書

後期化学_04_酸塩基pH

Group A (2,5-Dimethoxyphenyl type) 25D-NBMe (1) 25B-NBMe (2) 25I-NBMe (3) 25C-NBF () 25B-NBF (5) Group B (Benzofuran-2-yl type) Group C (-Alkoxy-3,5-d

From Evans Application Notes

(a) (b) X Ag + + X AgX F < Cl < Br < I Li + + X LiX F > Cl > Br > I (a) (b) (c)

温泉の化学 1

LCMS14003:UHPLC-Orbitrap質量分析計による環境汚染物質のターゲット分析、ノンターゲット分析

86 MS MS GC LC GC LC Fig. 1.MS 3. 質 量 分 析 計 の 構 成 1 試 料 導 入 部 2イオン 化 部 3イオン 分 離 部 4イオン 検 出 部 5データ 処 理 部 Pa Fig. 2.

HPLC カラム 総合カタログ 2015

JAJP

a b Chroma Graphein Chromatography

untitled

Microsoft Word - 14_LCMS_アクリルアミド

Microsoft PowerPoint - MonoTowerカタログ_ 最終.ppt [互換モード]

Donald Carl J. Choi, β ( )

n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m

Waters Sigma-Aldrich 1.0 mg/ml LC Waters Alliance HPLC ACQUITY UPLC H-Class Bio 30 cm Alliance HPLC UV ACQUITY UPLC TUV mm nm XBridge Protein B

Agilent BioHPLC HPLC/UHPLC /

GPC/SEC

PowerPoint プレゼンテーション

J. Mass Spectrom. Soc. Jpn.: 58(5), (2010)

RAA-05(201604)MRA対応製品ver6

C18 カラムのエンドキャッピングは ここまで進化した! 耐久性を実現する 技術とその性能 クロマニックテクノロジーズ塚本友康小島瞬長江徳和

MAbPac RPカラム


PALL NEWS vol.126 November 2017

untitled


イオンクロマトグラフプロダクトセレクションガイド

20 57


ONS60409_gencyo.indd

内容 1. セミ分取 HPLC システム 応用例 留意点 2. 超臨界流体クロマトグラフィー (SFC) を使用した分取の紹介


税関分析25 年の進歩

2 (FDA) 1 1 A D E K 1 LC UV 15 HPLC 3.5 UHPLC Agilent 12 Infinity LC Agilent 12 Infinity (G1311B) Agilent 12 Infinity (G13E) Agilent 12 Infinity (G131

δδ 1 2 δ δ δ δ μ H 2.1 C 2.5 N 3.0 O 3.5 Cl 3.0 S μ

メタボロミクスをはじめよう


gc-guide

36 th IChO : - 3 ( ) , G O O D L U C K final 1

untitled

untitled

LM837 Low Noise Quad Operational Amplifier (jp)

4_Laser.dvi

第90回日本感染症学会学術講演会抄録(I)

untitled

Transcription:

LC/MS MS LC/MS LC LC (APCI) (ESI) FAB 2 LC (APCI) 4.1.1.1 LC LC/MS LC MS LC 3 ph APCI/MS LC (1) APCI ESI 100% 100% ESI 4.1.1-1 LC 1.00cp 100 34

a 4.1.1-1 LC b ( /mpas) n- 0.23 36 0.5 99 0.31 69 n- 0.92 174 1.0 81 0.47 50 0.37 46 0.97 77 p- 0.64 140 0.37 68 0.59 111 0.65 80 0.23 35 0.57 62 0.44 40 0.54 118 0.4 66 0.79 57 0.4 80 0.32 56 1.54 107 0.45 77 0.37 57 2.24 189 4.4 184 0.38 56 0.67 101 0.37 82 0.94 116 2.39 82 n- 2.2 97 0.61 78 1.19 64 19.9 198 1.22 118 1.00 100 a b 20 C (2)pH 3 LC ph ph LC/APCI/MS ph 35

ph LC/APCI-MS ph ph LC LC/APCI/MS ph ph [M+NH 4 ] + 4.1.1-2 ph ph APCI-MS ph LC-APCI-MS H 3 PO 4 /KH 2 PO 4 /K 2 HPO 4 /KOH 2 11 / 3 6 / /NH 4 OH 5 9 / 8 10 /NH 4 OH / /NaOH 9 11 H 3 BO 3 /Na 3 BO 3 /NaOH 7 11 1 2 0.05 2 6 4 6 6 7 8 10 4.4 6.4 APCI ph 100mM 36

ph ph APCI/MS 4.1.1-2 ph 4.2.2 (3) LC LC/APCI/MS ph LC/APCI-MS APCI-MS LC/APCI-MS 4.1.1-3 4.1.1-3 LC-APCI-MS LC-APCI-MS 1- CH 3 CH 2 CH 2 SO 3 146.14 Na 1- CH 3 (CH 2 ) 3 SO 3 N 160.16 a 1- CH 3 (CH 2 ) 4 SO 3 N 174.19 a 1- CH 3 (CH 2 ) 5 SO 3 N 188.22 a 1- CH 3 (CH 2 ) 7 SO 3 N 202.24 a [CH 3 (CH 2 ) 5 ] 3 N 269.15 [CH 3 (CH 2 ) 6 ] 3 N 311.6 [CH 3 (CH2) 7 ] 3 N 353.67 (CH 3 CH 2 ) 4 NOH 147.26 [CH 3 (CH 2 ) 3 ] 4 NO 259.47 H 4.1.1.2 APCI/MS 37

(1) APCI APCI AH + + B BH + + A ( G<0 A,B A B AH + B BH + APCI AH + (CH 3 OH)H + ((CH 3 OH) 2 H + 182.1kcal/mol (1648kcal/mol) (202.3kcal/mol) A - + BH B - + AH BH A - A - BH A - BH 38

Linuron Diuron APCI 4.1.1-1 4.1.1-2 p-tert- ( 4.1.1-3 4.1.1-4) (C 60 ) APCI Linuron (200µg/ml) Scan ;100-400 Cap.Vol ; 3500V Corona current ; 4.0µA Drying gas temp. ; 350 Vaporizer temp.; 473 Drying gas flow ; 6.0 l/min Neb. Pressure ; 60psig positive mode Mobile phase ; MeOH:H 2 O=1:1 Flow rate ; 0.5ml/min Fragmentor voltage ; 80V Injection volume ; 5µl Instrument ; HP1100MSD Cl Cl N C N H O Linuron OCH 3 CH 3 4.1.1-1 Linuron APCI-MS Cl Cl N C N H O CH 3 CH 3 Diuron Diuron ( 0µg/ml) Scan ;100-400 Cap.Vol ; 3500V Corona current ; 4.0µA Drying gas temp. ; 350 Drying gas flow ; 6.0 l/min Vaporizer temp.; 473 Neb. Pressure ; 60psig positive mode Mobile phase ; MeOH:H 2 O=1:1 Flow rate ; 0.5ml/min Fragmentor voltage ; 50V Injection volume ; 5µl Instrument ; HP1100MSD 4.1.1-2 Diuron APCI-MS 39

CH OH 3 HO 17β-Estradiol 17β-estradiol (2.0µg/ml) Scan ;100-400 Cap.Vol ; 3500V Corona current ; 4.0µA Drying gas temp. ; 350 Vaporizer temp.; 473 Drying gas flow ; 6.0 l/min Neb. Pressure ; 60psig negative mode Mobile phase ; MeOH:H 2 O=1:1 Flow rate ; 0.5 ml/min Fragmentor voltage ;150V Injection volume ; 5µl Instrument ; HP1100MSD 4.1.1-3 17b-estradiol APCI-MS t-bu COOH 4-t-Butyl-benzoic acid p-t-butylbenzoic acid (5.0µg/ml) Scan ;100-400 Cap.Vol ; 3500V Corona current ; 4.0µA Drying gas temp. ; 350 Vaporizer temp.; 473 Drying gas flow ; 6.0 l/min Neb. Pressure ; 60psig negative mode Mobile phase ; MeOH:H 2 O=1:1 Flow rate ; 0.5 ml/min Fragmentor voltage ;70V Injection volume ; 5µl Instrument ; HP1100MSD 4.1.1-4 p-t-butylbenzoic acid APCI-MS 40

(2) APCI ESI ph ph LC-MS 0.05% 1 4.1.1-5 ph 4-10 APCI/MS ph 4.1.1-4 ph 4.1.1-4 APCI/MS Hitachi M-1200 AP/ES 1.0ml/min 100-400 50amu/sec 70V 1,800V 3,000V 90V 48 180 400 120 20ml APCI ESI [M+NH 4 ] + ESI 18- -6- ESI APCI H 2 O + 4.1.1-6 41

4.1.1-5 ph Dibenzo-18-crown-6-ether (5.0µg/ml) Scan ;100-400 Cap.Vol ; 3500V Corona current ; 4.0µA Drying gas temp. ; 350 Vaporizer temp.; 473 Drying gas flow ; 6.0 l/min Neb. Pressure ; 60psig positive mode Mobile phase ; MeOH:H 2 O=1:1 Flow rate ; 0.5 ml/min Fragmentor voltage ;50V Injection volume ; 5µl Instrument ; HP1100MSD O O O H + O O O O O O H 3 O + O O O 4.1.1-6 Dibenzo-18-crown-6-ether APCI-MS 42

(3) LC MS APCI ESI 4.1.1.3 (1) APCI MS MS LC ml/min 0.1-1.0ml/min LC/APCI/MS 1.0ml/min (2) CID(collision induced dissociation) CID SIM CID 4-50 166 4.1.1-7 90 166 122 4.1.1-8 972-100 150 ( 4.1.1-9) 100V 43

NO 2 4-Nitro-benzoic acid COOH 4-Nitrobenzoic acid (5.0µg/ml) Scan ;100-400 Cap.Vol ; 3500V Corona current ; 4.0µA Drying gas temp. ; 350 Vaporizer temp.; 473 Drying gas flow ; 6.0 l/min Neb. Pressure ; 60psig negative mode Mobile phase ; MeOH:H 2 O=1:1 Flow rate ; 0.5 ml/min Injection volume ; 5µl Instrument ; HP1100MSD 4.1.1-7 4-Nitrobenzoic acid APCI-MS (Fragmentor voltage ; 50V) 4.1.1-8 4-Nitrobenzoic acid APCI-MS (Fragmentor voltage ; 90V) α-cyclodextrin (1000µg/ml) Scan ;300-1000 Cap.Vol ; 3500V Corona current ; 4.0µA Drying gas temp. ; 350 Vaporizer temp.; 473 Drying gas flow ; 6.0 l/min Neb. Pressure ; 60psig negative mode Mobile phase ; MeOH:H 2 O=1:1 Flow rate ; 0.5 ml/min Fragmentor voltage ;150V Injection volume ; 5µl Instrument ; HP1100MSD 4.1.1-9 a-cyclodextrin APCI-MS 44

(3) APCI 3000 4000V -2500-3500V 3000V -2500V (4) APCI APCI 4.1.1-10 / 4.1.1-10 1ml/min 45

(5)LC/APCI-MS LC/APCI-MS LC APCI-MS LC MS a, : =1:1 : =1:1 b, g/ml SCAN c, d, LC a, b, ph a, LC-APCI-MS SCAN SIM) 4.1.1.4 APCI/MS 4.1.1-11 4.1.1-15 2,4- A, APCI/MS M-H ESI 2,3,3,4,5-pentachloro-4- biphenylol(10µg/ml) Scan ;100-450 Cap.Vol ; 3500V Corona current ; 4.0µA Drying gas temp. ; 350 Vaporizer temp.; 473 Drying gas flow ; 6.0 l/min Neb. Pressure ; 60psig negative mode Mobile phase ; MeOH:H 2 O=1:1 Flow rate ; 0.5 ml/min Fragmentor voltage ;130V Injection volume ; 5µl Instrument ; HP1100MSD 4.1.1-11 Cl Cl Cl 2,3,3,4,5-pentachloro-4-biphenylol APCI-MS 46 Cl OH Cl 2,3,3',4',5-Pentachlorobipheniyl-4-ol

2,2,3,4,5,5,6-heptachloro-4- biphenylol (10µg/ml) Scan ;100-450 Cap.Vol ; 3500V Corona current ; 4.0µA Drying gas temp. ; 350 Vaporizer temp.; 473 Drying gas flow ; 6.0 l/min Neb. Pressure ; 60psig negative mode Mobile phase ; MeOH:H 2 O=1:1 Flow rate ; 0.5 ml/min Fragmentor voltage ;130V Injection volume ; 5µl Instrument ; HP1100MSD 4.1.1-12 Cl Cl Cl Cl OH Cl Cl Cl 2,2',3,4',5,5',6-Heptachlorobipheniyl-4-ol 2,2,3,4,5,5,6-heptachloro-4-biphenylol APCI-MS 2,4-Dichlorophenol (5.0µg/ml) Scan ;100-400 Cap.Vol ; 3500V Corona current ; 4.0µA Drying gas temp. ; 350 Vaporizer temp.; 473 Drying gas flow ; 6.0 l/min Neb. Pressure ; 60psig negative mode Mobile phase ; MeOH:H 2 O=1:1 Flow rate ; 0.5 ml/min Fragmentor voltage ;90V Injection volume ; 5µl Instrument ; HP1100MSD OH Cl Cl 2,4-DIchlorophenol 4.1.1-13 2,4-Dichlorophenol APCI-MS 47

Bisphenol A (5.0µg/ml) Scan ;100-400 Cap.Vol ; 3500V Corona current ; 4.0µA Drying gas temp. ; Vaporizer temp.; 473 Drying gas flow ; 6.0 Neb. Pressure ; negative mode Mobile phase ; MeO :H 2 O=1:1 Flow rate ; 0.5 Fragmentor Injection volume ;µl Instrument ; 4.1.1-14 CH 3 HO C OH CH 3 Bisphenol Bisphenol A APCI-MS Diethylstilbestrol (10µg/ml) Scan ;100-400 Cap.Vol ; 3500V Corona current ; 4.0µA Drying gas temp. ; 350 Vaporizer temp.; 473 Drying gas flow ; 6.0 l/min Neb. Pressure ; 60psig negative mode Mobile phase ; MeOH:H 2 O=1:1 Flow rate ; 0.5 ml/min Fragmentor voltage ;130V Injection volume ; 5µl Instrument ; HP1100MSD 4.1.1-15 HO Diethylstilbestrol OH Diethylstilbestrol APCI-MS 48

(ESI) ESI ESI LC LC/MS/ESI ph MS 4.1.2.1 ESI ESI 4.1.2-1 4.1.2-1 ESI 1 1 cp Nm -1 1.0 0.073 100 0.61 0.022 78 0.37 0.029 82 1.19 0.022 64 2.20 0.024 97 2.39 0.021 82 2.95 0.025 83 0.32 0.024 56 1.80 0.038 101 1.22 0.028 118 0.44 0.028 40 2.24 0.043 189 (DMSO) 2 1 20 2 10% 49

4.1.2-1 ESI 4.1.2.2 ph LC ph LC LC/MS 4.1.2-2 4.1.2-3 35 NH 3 NH 4 + 50 CH 3 OH NH 4 + 68 CH 3 OH H 2 O NH 4 + 82 (CH 3 OH) 2 NH 4 + 36 H 2 O NH 4 + 54 (H 2 O ) 2 NH 4 + 77 (CH 3 COOH NH 3 NH 4-18) + 78 CH 3 COOH NH 4 + Negative (CH 3 COOH) 2-H 119 CH 3 COOH H 2 O-H 77 4.1.2-4 41 CH 3 CN + 59 + CH 3 CN NH 4 77 + CH 3 CN H 2 O NH 4 100 + (CH 3 CN) 2 NH 4 ESI ph H 3.2.3-2 50

4.1.2-2 4.1.2-4 ph ESI (10mM ) 4.1.2.3 (IPC) IPC IPC IPC ph ESI IPC 3.2.3-4 3.2.3-5 LC IPC LC/MS LC/MS IPC 4.1.2.4 ESI ESI ESI (1) 51

ESI ( ) ( ) N M+H M-H 4.1.2-1 N R HA R 1 R 1 N R A R 3 R 3 Base Acid Sample (M+H) O O R C OH B R C O H B Acid Base Sample (M-H) (2) (+) R-NH 2 R-NH-R ESI R 2 -PH R 2 -PH ( ) R-OH R-SH R-OR R-C=O ( RCOOH ) RSO H RPO H ( ) ESI ±3 5kV 4.1.2-1 0.2mm 52

0.1mm LC/MS LC 3.2.2 LC/MS ESI LC LC/MS LC/MS (3) LC MS 4.1.2-5 MS MS LC 4.1.2-2 2.0 1.0 PB APCI TSP ESI (ml/min) Frit-FAB or CF-FAB 4.1.2-2 LC/MS APCI Atomospheric pressure chemical ionization ESI Electrospray ionization PB Particle beam TSP Themospray Frit-FAB Frit-Fast atom bombardment 53 CF-FAB Continuous flow-fast atom bombardment

4.1.2-5 LC MS ( ) ( cm 3 /min) column Conventional Semi-micro Micro mm 4.0~4.6 1.0~2.0 0.2~0.5 ml/min 1.0 0.2 0.005 Methanol 550 110 3 Water 1240 248 6 ESI 4.1.2-6 LC 4.1.2.1 (mm) 0.32 3-8 ESI 1.0 30-60 0.1mm 2.0 200-400 4.6 800-2000 l 200 l ESI 0.2ml/min ( 4.6mm 150mm) 1ml/min LC ESI Tee 4.1.2-6 LC (4) LC ESI Taylor cone ±3 5kV MS (5) ( ) 54 ( l/min)

( ) ( ) API CID(collision induced dissociation) ( ) CID (6) ESI LC LC ph HFBA TFA 4.1.2-4 50 M [M+Na] + ESI 4.1.2-3 Mixing Tee HPLC (UV) (API Needle) Pump 4.1.2-3 55

20 Signal Signal (%) 10 10 15 16 1.5 6 Formic Acetic Propionic Butyric Valeric Acid 4.1.2-4 20% HP 1998 LC/MSD ESI MS 4.1.2-5 0% 0.05% 0.1% 0.5% Signal ratio 2.0 1.0 benzoic acid o-toluic acid salicylic acid phenoxacetic acid 0% 0.05% 0.1% 0.5% 4.1.2-5 56

4.1.2.5 ESI (M+nH) n+ (M-nH) n- QMS QMS n2=n1+1 n n1< n2 n1=m1/(m2-m1) M1=n1(m1- ) mn m1< m2 Mn MW=ave(M1,M2,M3.) MW 4.1.2-6 =82.5 =115.5 =173.3 m1:496 m1 496 m2:578.5 m2 578.5 m3:694.0 m3 694.0 m4:867.3 m4 m/z 500 600 700 800 900 4.1.2-6 n1=496 (578.5 496) M1=6(496-1) =6.012 = 2970.0 n2=578.5 (694.0 578.5) M2=5(578.5-1) =5.008 =2887.5 n3=694.0 (867.3 694.0) M3=4(694.0-1) =4.004 =2772 =M1 M2 M3 --- 57

4.1.2.6 LC/ESI/MS LC/ESI/MS LC ESI/MS a ( LC ) b SCAN g/ml c ( ) LC a b ph ( LC ) a --- (LC/MS ) LC LC-ESI-MS (SCAN SIM) 4.1.2.7 Paul Kebarle and Liang Tang ;AnalChem.,1993,65,972A-986A Robert D.Voyksner; Environ. Sci. Technol.,1994,28,118A-127A 15 LC/MS ( ) 58

CF(Frit)-FAB 4.1.3.1 LC Frit-FAB API Frit API LC Frit-FAB LC Frit-FAB (1) Frit-FAB FAB Frit- FAB 4.1.3.6 1) 4.1.3-1 (1:1) ph 20mM 1v/v% m/z 59 CH 3 COO - m/z 151 [Gly + CH 3 COO] - m/z 91 [Gly-H] - m/z 93 [Gly+H] + m/z 185 [2Gly+H] + 4.1.3-1 59

Positive Negative 4.1.3-1 4.1.3-1 JMS-700 Frit-FAB 0.5 ml/min FAB Xe kv 55 scan 80 SIM 10 kv 10-2 torr MS (Scan) m/z 45 500 1 sec/cycle MS (SIM) 100msec/ch 60

(2) Frit-FAB ph LC-Frit-FAB-MS K. Kamei, et al.(1988) ph HPLC APCI ESI FAB 4.1.3.2 (1) 8 Frit-FAB 4.1.3-2 4.1.3-2 20mM 0.2 % / (1:1) 100mg/L 20 L 4.1.3-1 FAB 4.1.3-4.1.3-10 APCI ESI a) [M-H] - [M+H] + M + FAB b) 61

1:1 m/z 208 Frit-FAB c) Frit-FAB 4.1.3-2 Frit-FAB [mg/ml] CAS 1 10380-28-6 0.04 0.4 2 137-26-8 0.006 0.06 0.06 3 3337-71-1 2 4 * 55335-06-3 0.06 5 (SAP) 741-58-2 1 0.1 6 (MCPP) 16484-77-8 0.05 7 13861-41-3 0.2 8 80844-07-1 0.08 * 62

4.1.3-2 63

H 2N SO2 + [M-H] - [M + H] + 4.1.3-3 FAB : : [M + H]+ [M-H] - 4.1.3-4 FAB : : CH3 + Cl O + H [M-H] - CH3 + Cl O-CH CH 3 M [M-H] [M-H] - - 4.1.3-5 FAB : : 64

N O Cu + H + N O - 4.1.3-6 FAB : : H 2NCH 2CH 2S 2P(OCH(CH 3) 2) 2 + H + S -SP(OCH(CH 3) 2) 2-4.1.3-7 FAB : : S -SCN(CH 3 ) 2-4.1.3-8 FAB : : 65

N + Cl CH 2 Cl N CH2 N NH 2 + N H [M-H] - [M + H] + 129 256 4.1.3-9 FAB : : CH3CH2O C(CH 3) 2 + 163 4.1.3-10 FAB : : 66

(2) 1 4.1.3-4 4.1.3-4 m/z 208 100 66 33 33 231 100 66 33 33 258 50 50 50 100 214 100 100 100 100 211 100 66 33 33 163 25 25 100 75 100 a) ph 20mM 0.2 % / (1:1) ph b) 67

c) FAB - ph HPLC MS (3) Frit-FAB m- (NBA) NBA 0.1% HPLC 0.2% 4.1.3.3 (1) HPLC MS 5 10 L/min (2) FAB Frit FAB 50 / (4:6) 50 68

80 FAB 4.1.3.4 LC-Frit-FAB-MS LC-Frit-FAB-MS LC Frit-FAB-MS LC MS (1) (2)LC (3) (4)LC-Frit-FAB-MS 4.1.3.5 FAB FAB Frit Frit-FAB Frit-FAB ppb Frit-FAB ppb 69

4.1.3.6 1) Application Note, MS42, MS43, MS55, MS62, MS63, MS72, MS101, MS109, MS131, MS144, MS159 2)K. Kamei, K. Kitahara, A. Momose, K. Matsuura, H. Yuki : Mass Spectrosc. (Japan), vol.36, 115(1988) 70